|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.40 USD | -2.10% |
|
-4.97% | -0.37% |
| Mar. 03 | Immunome 2025 Net Loss Narrows | MT |
| Mar. 03 | Earnings Flash (IMNM) Immunome Posts Full Year 2025 Loss $2.43, vs. FactSet Est of $2.24 Loss | MT |
| Capitalization | 2.42B 2.09B 1.89B 1.81B 3.29B 223B 3.39B 22.33B 8.9B 107B 9.08B 8.89B 385B | P/E ratio 2026 * |
-8.7x | P/E ratio 2027 * | -9.5x |
|---|---|---|---|---|---|
| Enterprise value | 1.99B 1.72B 1.55B 1.48B 2.7B 183B 2.78B 18.32B 7.3B 87.58B 7.45B 7.3B 315B | EV / Sales 2026 * |
447x | EV / Sales 2027 * | 26.8x |
| Free-Float |
64.95% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.10% | ||
| 1 week | -4.97% | ||
| Current month | -2.10% | ||
| 1 month | -8.59% | ||
| 3 months | +9.80% | ||
| 6 months | +121.07% | ||
| Current year | -0.37% |
| 1 week | 19.85 |  | 22.16 |
| 1 month | 19.85 | | 23.35 |
| Current year | 19.15 | | 27.65 |
| 1 year | 5.15 | | 27.65 |
| 3 years | 4.22 | | 30.96 |
| 5 years | 2.09 | | 41.66 |
| 10 years | 2.09 | | 63.78 |
| Manager | Title | Age | Since |
|---|---|---|---|
Clay Siegall
CEO | Chief Executive Officer | 65 | 2023-10-01 |
Max Rosett
DFI | Director of Finance/CFO | 36 | 2024-01-01 |
Philip Tsai
CTO | Chief Tech/Sci/R&D Officer | 58 | 2024-06-26 |
| Director | Title | Age | Since |
|---|---|---|---|
Philip Wagenheim
BRD | Director/Board Member | 55 | 2016-12-31 |
Clay Siegall
CHM | Chairman | 65 | 2023-10-01 |
Isaac Barchas
BRD | Director/Board Member | 58 | 2023-10-01 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -7.56% | 0% | 293,477 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.10% | -4.97% | +145.13% | +396.52% | 2.42B | |
| -0.66% | +0.42% | +16.24% | +92.76% | 44.8B | |
| -1.34% | +0.95% | +50.72% | +15.79% | 40.35B | |
| -3.09% | -6.99% | +89.15% | +675.31% | 30.05B | |
| +8.28% | -12.49% | -7.67% | -28.72% | 21.8B | |
| -2.71% | -0.90% | +48.81% | -30.04% | 19.09B | |
| +0.38% | -0.70% | +28.42% | -29.30% | 16.72B | |
| -3.31% | +8.92% | +55.17% | +180.20% | 13.53B | |
| -1.53% | +4.55% | -13.08% | +979.19% | 12.47B | |
| -4.48% | +4.92% | +65.53% | - | 12.1B | |
| Average | -1.05% | +1.66% | +47.84% | +250.19% | 21.33B | |
| Weighted average by Cap. | -0.76% | +0.01% | +39.47% | +193.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.44M 3.84M 3.46M 3.31M 6.04M 409M 6.21M 40.93M 16.32M 196M 16.65M 16.3M 705M | 82.21M 71.04M 64.14M 61.34M 112M 7.58B 115M 758M 302M 3.63B 308M 302M 13.06B |
| Net income | -263M -228M -205M -197M -358M -24.29B -368M -2.43B -968M -11.61B -988M -967M -41.83B | -256M -222M -200M -191M -349M -23.64B -358M -2.36B -942M -11.3B -962M -942M -40.72B |
| Net Debt | -435M -376M -339M -324M -591M -40.1B -608M -4.01B -1.6B -19.18B -1.63B -1.6B -69.07B | -216M -187M -169M -161M -294M -19.95B -302M -1.99B -795M -9.54B -812M -795M -34.35B |
Employees
177
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-03-11 | 21.40 $ | -2.10% | 664,320 |
| 26-03-10 | 21.86 $ | +2.48% | 1,029,118 |
| 26-03-09 | 21.33 $ | +1.38% | 975,789 |
| 26-03-06 | 21.04 $ | +0.43% | 1,831,806 |
| 26-03-05 | 20.95 $ | -6.97% | 2,243,161 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
21.40USD
Average target price
35.54USD
Spread / Average Target
+66.07%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- IMNM Stock
Select your edition
All financial news and data tailored to specific country editions
